An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study
暂无分享,去创建一个
[1] F. Rademakers,et al. Quantitative dobutamine stress echocardiography for the early detection of cardiac allograft vasculopathy in heart transplant recipients , 2007, Heart.
[2] Douglas G Altman,et al. Developing a prognostic model in the presence of missing data: an ovarian cancer case study. , 2003, Journal of clinical epidemiology.
[3] Patrick Royston,et al. Reporting performance of prognostic models in cancer: a review , 2010, BMC medicine.
[4] J. Robson,et al. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease , 2007, Heart.
[5] Holly Janes,et al. Assessing the Value of Risk Predictions by Using Risk Stratification Tables , 2008, Annals of Internal Medicine.
[6] J. Hippisley-Cox,et al. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study , 2007, Heart.
[7] Qingxia Chen,et al. Dealing with missing predictor values when applying clinical prediction models. , 2009, Clinical chemistry.
[8] N. Cook,et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.
[9] Douglas G Altman,et al. Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines , 2009, BMC medical research methodology.
[10] I. Graham,et al. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. , 2009, Journal of the American College of Cardiology.
[11] Patrick Royston,et al. Multivariable Model-Building: A Pragmatic Approach to Regression Analysis based on Fractional Polynomials for Modelling Continuous Variables , 2008 .
[12] A. Sheikh,et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2 , 2008, BMJ : British Medical Journal.
[13] D G Altman,et al. What do we mean by validating a prognostic model? , 2000, Statistics in medicine.
[14] J. Hippisley-Cox,et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study , 2007, BMJ : British Medical Journal.
[15] R. Marshall. Cardiovascular risk can be represented by scaled rectangle diagrams. , 2009, Journal of clinical epidemiology.
[16] Angela Cooper,et al. Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance , 2008, BMJ : British Medical Journal.
[17] Gary S Collins,et al. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study , 2009, BMJ : British Medical Journal.
[18] Patrick Royston,et al. Explained Variation for Survival Models , 2006 .
[19] H. Flor. QrIsK valIdatIon and evaluatIon , 2009 .
[20] Patrick Royston,et al. Reporting methods in studies developing prognostic models in cancer: a review , 2010, BMC medicine.
[21] Patrick Royston,et al. A new measure of prognostic separation in survival data , 2004, Statistics in medicine.
[22] Richard D Riley,et al. Ten steps towards improving prognosis research , 2009, BMJ : British Medical Journal.
[23] K. Anderson,et al. Cardiovascular disease risk profiles. , 1991, American heart journal.
[24] Martin Utley,et al. Monitoring risk-adjusted outcomes in congenital heart surgery: does the appropriateness of a risk model change with time? , 2009, The Annals of thoracic surgery.
[25] Joseph Eliahoo,et al. Cardiac surgery risk modeling for mortality: a review of current practice and suggestions for improvement. , 2004, The Annals of thoracic surgery.
[26] J. Schafer. Multiple imputation: a primer , 1999, Statistical methods in medical research.
[27] M. Woodward,et al. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC) , 2005, Heart.
[28] F. Harrell,et al. Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association , 2009, Circulation.
[29] Yvonne Vergouwe,et al. Prognosis and prognostic research: validating a prognostic model , 2009, BMJ : British Medical Journal.
[30] Yvonne Vergouwe,et al. Development and validation of a prediction model with missing predictor data: a practical approach. , 2010, Journal of clinical epidemiology.
[31] P. Glasziou,et al. QRISK may be less useful , 2009, BMJ : British Medical Journal.
[32] H. Tunstall-Pedoe,et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.
[33] L. Irwig,et al. Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide. , 2008, Archives of internal medicine.
[34] R. Jackson. Cardiovascular risk prediction: are we there yet? , 2007, Heart.
[35] E Graf,et al. Assessment and comparison of prognostic classification schemes for survival data. , 1999, Statistics in medicine.